1243 results
News
90 years - The animal health company is firmly established in the world's Top 10.
A family-owned and independent company Vetoquinol has managed to preserve its family ownership and independence while pursuing a growth strategy aimed at focusing its efforts and resources on high-potential markets. In 2023, the company is the 8th largest animal health pharmaceutical company in the...
News
Q1 2023 sales: €145m Q1 2023 essentials sales: €87m
Matthieu Frechin, Chief Executive Officer of Vetoquinol, said: "While we remain aware of the macro-economic uncertainty and the normalisation of our post-Covid market, we are actively investing in the deployment of our strategic plan, the main lines of which performed well in the first quarter."...
Publication
Q1 2023 Sales: €145M
Vetoquinol recorded sales of €145 million for the first three months of the 2023 financial year, up 7.7% on a reported basis and 7.2% at constant exchange rates.
Publication
BALO : Avis de convocation / avis de réunion
Mesdames et Messieurs les actionnaires sont convoqués le jeudi 25 mai 2023 à 11h00 au siège social, Magny-Vernois 70200 LURE, en Assemblée générale mixte, à l’effet de délibérer sur l’ordre du jour et les projets de résolutions ci-après.
Publication
Document d’enregistrement universel (URD) 2022 version XBRL
Document d'enregistrement universel 2022 incluant le rapport financier annuel
Publication
Availability of the 2022 universal registration document
On 13 April 2023, Vetoquinol filed its 2022 Universal Registration Document with the Autorité des Marchés Financiers (AMF) in ESEF (European Single Electronic Format).
Publication
Monthly information regarding the total number of voting rights - March 2023
As per articles L233‐8‐II of « Code de Commerce » and 223.16 of the «Reglement Général de L’Autorité des Marchés Financiers»